glatiramer acetate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
4880 147245-92-9

Description:

MoleculeDescription

Synonyms:

  • glatiramer acetate
  • copaxone
  • protiramer
A random polymer of L-ALANINE, L-GLUTAMIC ACID, L-LYSINE, and L-TYROSINE that structurally resembles MYELIN BASIC PROTEIN. It is used in the treatment of RELAPSING-REMITTING MULTIPLE SCLEROSIS.
  • Molecular weight: 559.66
  • Formula: C25H45N5O9
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 63.32
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
20 mg P

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

None

Approvals:

DateAgencyCompanyOrphan
Dec. 20, 1996 FDA TEVA PHARMS USA

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Multiple sclerosis relapse 4140.91 15.37 1433 51123 50872 90525019
Injection site reaction 3112.75 15.37 1360 51196 90720 90485171
Injection site pain 1920.57 15.37 1214 51342 172485 90403406
Injection site erythema 1628.79 15.37 894 51662 97608 90478283
Injection site mass 1522.09 15.37 547 52009 21543 90554348
Immediate post-injection reaction 1169.29 15.37 207 52349 257 90575634
Injection site swelling 1105.13 15.37 585 51971 59254 90516637
Injection site pruritus 990.30 15.37 525 52031 53309 90522582
Multiple sclerosis 815.58 15.37 373 52183 27467 90548424
Injection site urticaria 776.20 15.37 317 52239 17694 90558197
Flushing 684.69 15.37 497 52059 87994 90487897
Injection site bruising 500.85 15.37 335 52221 51972 90523919
Fall 485.25 15.37 941 51615 480869 90095022
Chills 464.70 15.37 472 52084 131509 90444382
Injection site necrosis 380.11 15.37 101 52455 1400 90574491
Off label use 340.09 15.37 109 52447 1102143 89473748
Injection site atrophy 287.90 15.37 72 52484 772 90575119
Injection site induration 283.78 15.37 133 52423 10335 90565556
Urticaria 280.68 15.37 583 51973 312151 90263740
Lipoatrophy 280.26 15.37 59 52497 266 90575625
Product dose omission issue 264.33 15.37 546 52010 291141 90284750
Central nervous system lesion 240.84 15.37 123 52433 11523 90564368
Therapy cessation 240.29 15.37 186 52370 36175 90539716
Influenza like illness 229.89 15.37 258 52298 80353 90495538
Hypoaesthesia 229.00 15.37 539 52017 313671 90262220
Balance disorder 227.55 15.37 281 52275 96799 90479092
Palpitations 216.19 15.37 327 52229 136401 90439490
Chest discomfort 216.07 15.37 329 52227 138036 90437855
Product substitution issue 208.39 15.37 130 52426 17878 90558013
Injection site irritation 202.85 15.37 89 52467 5926 90569965
Injection site warmth 201.57 15.37 126 52430 17389 90558502
Tremor 196.44 15.37 333 52223 152840 90423051
Gait disturbance 187.66 15.37 445 52111 260051 90315840
Magnetic resonance imaging abnormal 183.74 15.37 71 52485 3415 90572476
Injection site haemorrhage 183.06 15.37 143 52413 28175 90547716
Lipodystrophy acquired 181.78 15.37 57 52499 1457 90574434
Infusion related reaction 180.05 15.37 17 52539 416763 90159128
Optic neuritis 179.44 15.37 95 52461 9583 90566308
Throat tightness 177.97 15.37 143 52413 29341 90546550
Rheumatoid arthritis 176.52 15.37 8 52548 362606 90213285
Injection site scar 174.94 15.37 53 52503 1204 90574687
Embolia cutis medicamentosa 171.08 15.37 45 52511 598 90575293
Contraindicated product administered 166.62 15.37 4 52552 320135 90255756
Needle fatigue 166.41 15.37 34 52522 128 90575763
Glossodynia 160.29 15.37 6 52550 321773 90254118
Injection related reaction 160.10 15.37 48 52508 1051 90574840
Joint swelling 157.79 15.37 48 52508 503252 90072639
Abortion 151.15 15.37 58 52498 2737 90573154
Systemic lupus erythematosus 150.50 15.37 17 52539 361879 90214012
Seizure 139.50 15.37 287 52269 152342 90423549
Dyspnoea 137.28 15.37 926 51630 880029 89695862
Urinary tract infection 131.64 15.37 433 52123 305199 90270692
Pericarditis 131.31 15.37 6 52550 270145 90305746
Injection site rash 128.66 15.37 109 52447 24064 90551827
Acute kidney injury 128.41 15.37 17 52539 320370 90255521
Arthropathy 123.99 15.37 30 52526 366212 90209679
Burning sensation 122.56 15.37 167 52389 63285 90512606
Injection site discolouration 122.48 15.37 73 52483 9247 90566644
Toxicity to various agents 120.97 15.37 13 52543 287833 90288058
Injection site indentation 117.42 15.37 29 52527 294 90575597
Lower respiratory tract infection 117.31 15.37 7 52549 250652 90325239
Stomatitis 116.48 15.37 12 52544 274686 90301205
General physical health deterioration 112.79 15.37 33 52523 355082 90220809
Paraesthesia 112.57 15.37 360 52196 249966 90325925
Wound 112.47 15.37 20 52536 302960 90272931
Motor dysfunction 107.07 15.37 89 52467 19141 90556750
Erythema 105.18 15.37 332 52224 228914 90346977
Secondary progressive multiple sclerosis 104.51 15.37 38 52518 1541 90574350
Therapy change 103.71 15.37 63 52493 8259 90567632
Folliculitis 101.08 15.37 4 52552 204349 90371542
Psoriatic arthropathy 99.36 15.37 9 52547 228326 90347565
Loss of consciousness 96.98 15.37 236 52320 140002 90435889
Anaemia 96.34 15.37 42 52514 352760 90223131
Swelling face 95.24 15.37 170 52386 81182 90494709
Product use issue 93.76 15.37 37 52519 329882 90246009
Memory impairment 93.54 15.37 289 52267 196955 90378936
Irritable bowel syndrome 93.51 15.37 7 52549 207441 90368450
Coronavirus infection 93.45 15.37 51 52505 5464 90570427
Abdominal discomfort 92.99 15.37 84 52472 477244 90098647
Chest pain 91.92 15.37 398 52158 319247 90256644
Product use in unapproved indication 91.85 15.37 40 52516 336196 90239695
Depression 90.07 15.37 379 52177 300222 90275669
Breast cancer 86.89 15.37 130 52426 53631 90522260
Diarrhoea 85.20 15.37 271 52285 938919 89636972
Fibromyalgia 84.91 15.37 10 52546 206259 90369632
Feeling cold 83.58 15.37 91 52465 27374 90548517
Feeling hot 81.24 15.37 155 52401 77853 90498038
Injection site nodule 80.36 15.37 43 52513 4430 90571461
Injection site inflammation 79.75 15.37 43 52513 4498 90571393
Blood cholesterol increased 78.78 15.37 13 52543 207999 90367892
Decreased appetite 78.53 15.37 62 52494 376478 90199413
Impaired healing 77.63 15.37 20 52536 234179 90341712
Blister 76.82 15.37 26 52530 254972 90320919
Wheezing 75.79 15.37 22 52534 238058 90337833
Intentional product use issue 74.87 15.37 17 52539 216875 90359016
Osteoarthritis 74.64 15.37 12 52544 195718 90380173
Hepatic enzyme increased 73.23 15.37 61 52495 360675 90215216
Immune reconstitution inflammatory syndrome 72.07 15.37 47 52509 6972 90568919
C-reactive protein increased 71.74 15.37 10 52546 181379 90394512
Type 2 diabetes mellitus 70.01 15.37 16 52540 203228 90372663
Injury 69.06 15.37 15 52541 197334 90378557
Fatigue 68.69 15.37 992 51564 1153031 89422860
Therapeutic product effect decreased 68.25 15.37 38 52518 277533 90298358
Muscle spasms 66.60 15.37 306 52250 251577 90324314
Neutropenia 64.23 15.37 25 52531 224879 90351012
Joint range of motion decreased 62.80 15.37 4 52552 135639 90440252
Expanded disability status scale score increased 62.76 15.37 22 52534 801 90575090
Muscular weakness 61.40 15.37 260 52296 206406 90369485
Progressive multifocal leukoencephalopathy 60.53 15.37 59 52497 15596 90560295
Arthralgia 60.25 15.37 240 52316 778282 89797609
Thrombocytopenia 59.94 15.37 23 52533 208702 90367189
Liver injury 59.60 15.37 13 52543 170554 90405337
Drug interaction 59.56 15.37 44 52512 276409 90299482
Dizziness 59.28 15.37 561 51995 588723 89987168
Ill-defined disorder 58.99 15.37 17 52539 184874 90391017
Hypertension 57.83 15.37 111 52445 457421 90118470
Skin reaction 57.37 15.37 62 52494 18491 90557400
Bladder disorder 56.14 15.37 48 52508 10724 90565167
Pneumonia 55.72 15.37 187 52369 637872 89938019
Oedema 54.39 15.37 24 52532 200271 90375620
JC polyomavirus test positive 52.27 15.37 24 52532 1778 90574113
Sinusitis 51.92 15.37 74 52482 343014 90232877
Completed suicide 50.79 15.37 11 52545 145047 90430844
Peroneal nerve palsy 50.64 15.37 35 52521 5713 90570178
Hyperhidrosis 50.62 15.37 184 52372 136121 90439770
Injection site vesicles 50.30 15.37 31 52525 4169 90571722
Injection site infection 49.28 15.37 25 52531 2307 90573584
Abortion spontaneous 48.56 15.37 101 52455 53955 90521936
Bursitis 48.15 15.37 9 52547 131645 90444246
Injection site haematoma 47.00 15.37 36 52520 6886 90569005
Therapeutic product effect incomplete 46.99 15.37 27 52529 193869 90382022
Blood creatinine increased 46.90 15.37 3 52553 101383 90474508
Confusional state 46.79 15.37 96 52460 386109 90189782
Hypercholesterolaemia 46.63 15.37 3 52553 100889 90475002
Cognitive disorder 46.03 15.37 115 52441 69292 90506599
Lung disorder 45.61 15.37 15 52541 149868 90426023
Therapy interrupted 45.45 15.37 94 52462 50014 90525877
Platelet count decreased 44.79 15.37 12 52544 136957 90438934
Pulmonary fibrosis 44.76 15.37 5 52551 107498 90468393
Pancytopenia 44.46 15.37 8 52548 120255 90455636
Malignant neoplasm progression 44.42 15.37 5 52551 106865 90469026
Peripheral swelling 44.11 15.37 110 52446 412996 90162895
Feeling abnormal 44.04 15.37 203 52353 167032 90408859
Infection 43.87 15.37 90 52466 362004 90213887
Asthma 43.18 15.37 46 52510 242114 90333777
Hemiparesis 43.15 15.37 71 52485 31748 90544143
Muscle spasticity 42.85 15.37 75 52481 35247 90540644
Dry mouth 42.69 15.37 27 52529 184032 90391859
Paralysis 42.04 15.37 42 52514 11436 90564455
Hypotension 41.91 15.37 78 52478 325319 90250572
Heart rate increased 41.57 15.37 152 52404 112750 90463141
Incorrect dose administered by device 41.52 15.37 31 52525 5706 90570185
Obesity 41.28 15.37 6 52550 105501 90470390
Relapsing-remitting multiple sclerosis 41.14 15.37 16 52540 783 90575108
Dyspepsia 40.81 15.37 33 52523 198127 90377764
Delirium 40.68 15.37 6 52550 104353 90471538
Injection site hypoaesthesia 40.30 15.37 15 52541 650 90575241
Anaphylactic reaction 40.29 15.37 127 52429 87397 90488494
Injection site scab 40.06 15.37 15 52541 661 90575230
Autonomic dysreflexia 40.03 15.37 13 52543 373 90575518
Visual impairment 39.65 15.37 167 52389 132198 90443693
Hyponatraemia 39.53 15.37 14 52542 133524 90442367
Vision blurred 39.36 15.37 147 52409 110146 90465745
Trigeminal neuralgia 38.40 15.37 26 52530 4105 90571786
Lymphadenopathy 38.20 15.37 83 52473 45692 90530199
Gastrointestinal disorder 38.19 15.37 56 52500 256631 90319260
Gastrooesophageal reflux disease 37.75 15.37 25 52531 166312 90409579
Circumstance or information capable of leading to device use error 37.67 15.37 11 52545 219 90575672
Intentional overdose 37.50 15.37 5 52551 93829 90482062
Wrong device used 37.48 15.37 8 52548 39 90575852
Movement disorder 37.01 15.37 63 52493 28956 90546935
Discomfort 36.90 15.37 64 52492 274271 90301620
Anaphylactic shock 36.89 15.37 66 52490 31551 90544340
Injection site ulcer 36.72 15.37 14 52542 649 90575242
Muscle tightness 36.55 15.37 42 52514 13397 90562494
Head injury 36.26 15.37 65 52491 31123 90544768
Sleep disorder 35.99 15.37 37 52519 197993 90377898
Demyelination 35.90 15.37 33 52523 8107 90567784
No reaction on previous exposure to drug 35.69 15.37 9 52547 100 90575791
Lip swelling 35.69 15.37 73 52483 38537 90537354
Product storage error 35.67 15.37 51 52505 20190 90555701
Night sweats 35.63 15.37 15 52541 128751 90447140
Therapeutic response decreased 35.34 15.37 5 52551 89724 90486167
Band sensation 35.21 15.37 16 52540 1157 90574734
Speech disorder 35.05 15.37 80 52476 45505 90530386
Insurance issue 34.55 15.37 37 52519 10921 90564970
Injection site injury 34.39 15.37 15 52541 984 90574907
Injection site discomfort 34.12 15.37 28 52528 5912 90569979
Pharyngeal oedema 34.07 15.37 41 52515 13730 90562161
Inflammation 34.03 15.37 32 52524 178560 90397331
Drug abuse 33.85 15.37 4 52552 82343 90493548
Psoriasis 33.81 15.37 22 52534 147732 90428159
Lymphopenia 33.68 15.37 53 52503 22828 90553063
Wound infection 33.53 15.37 10 52546 106392 90469499
Urinary incontinence 32.36 15.37 69 52487 37497 90538394
Injection site anaesthesia 32.17 15.37 7 52549 38 90575853
Weight increased 32.13 15.37 129 52427 417798 90158093
Electrocardiogram QT prolonged 31.11 15.37 3 52553 72453 90503438
Pleural effusion 31.06 15.37 13 52543 111978 90463913
Cough 30.88 15.37 110 52446 368852 90207039
Skin indentation 30.77 15.37 7 52549 48 90575843
Anxiety 30.60 15.37 294 52262 309478 90266413
Malignant melanoma 30.39 15.37 37 52519 12539 90563352
Haemoglobin decreased 29.72 15.37 30 52526 161926 90413965
Relapsing multiple sclerosis 29.24 15.37 9 52547 216 90575675
Nephrolithiasis 29.12 15.37 78 52478 49007 90526884
Maternal exposure during breast feeding 28.97 15.37 26 52530 6194 90569697
Sensory disturbance 28.89 15.37 40 52516 15373 90560518
Grip strength decreased 28.63 15.37 9 52547 92567 90483324
Nasopharyngitis 28.63 15.37 130 52426 406974 90168917
Limb discomfort 28.39 15.37 66 52490 37994 90537897
Upper respiratory tract infection 28.16 15.37 20 52536 128298 90447593
Alopecia 28.14 15.37 170 52386 494901 90080990
Neutrophil count decreased 28.14 15.37 4 52552 71528 90504363
Wrong technique in product usage process 27.73 15.37 98 52458 71473 90504418
Progressive multiple sclerosis 27.72 15.37 14 52542 1280 90574611
Weight decreased 27.50 15.37 120 52436 379790 90196101
Vertigo 27.40 15.37 96 52460 69715 90506176
Hyperkalaemia 27.09 15.37 3 52553 64961 90510930
Haemorrhagic adrenal infarction 26.92 15.37 6 52550 37 90575854
Hypokalaemia 26.78 15.37 22 52534 131094 90444797
Constipation 26.64 15.37 79 52477 280316 90295575
Medication error 26.59 15.37 8 52548 84644 90491247
Device mechanical issue 26.57 15.37 13 52543 1110 90574781
Septic shock 26.35 15.37 8 52548 84152 90491739
Sciatica 26.19 15.37 13 52543 101369 90474522
Hot flush 26.17 15.37 85 52471 59403 90516488
Back pain 26.08 15.37 290 52266 316885 90259006
Ankle fracture 25.68 15.37 44 52512 20326 90555565
Injury associated with device 25.55 15.37 21 52535 4443 90571448
Condition aggravated 25.40 15.37 222 52334 595323 89980568
Maternal exposure during pregnancy 25.11 15.37 319 52237 359744 90216147
Renal impairment 25.08 15.37 15 52541 105406 90470485
Productive cough 24.73 15.37 7 52549 77056 90498835
Hypersensitivity 24.55 15.37 385 52171 454292 90121599
Wrong technique in device usage process 24.47 15.37 23 52533 5812 90570079
Bradycardia 24.46 15.37 9 52547 83838 90492053
Interstitial lung disease 24.40 15.37 7 52549 76398 90499493
Arthritis 24.39 15.37 37 52519 167278 90408613
Foot deformity 24.27 15.37 3 52553 59648 90516243
Gastrointestinal haemorrhage 24.19 15.37 11 52545 90237 90485654
Cardiac failure 24.12 15.37 17 52539 109479 90466412
Abdominal pain 23.48 15.37 134 52422 395587 90180304
Panic attack 23.37 15.37 49 52507 26316 90549575
Skin mass 23.27 15.37 25 52531 7405 90568486
Kinematic imbalances due to suboccipital strain 23.04 15.37 4 52552 4 90575887
Taste disorder 22.95 15.37 4 52552 61542 90514349
Needle issue 22.94 15.37 34 52522 13900 90561991
Abdominal pain upper 22.92 15.37 107 52449 332567 90243324
Oedema peripheral 22.85 15.37 75 52481 257840 90318051
Respiratory failure 22.81 15.37 21 52535 118397 90457494
Hypoaesthesia oral 22.77 15.37 36 52520 15564 90560327
Monoplegia 22.55 15.37 18 52538 3656 90572235
Injection site paraesthesia 22.45 15.37 10 52546 690 90575201
Rectal haemorrhage 22.32 15.37 10 52546 82734 90493157
Nail disorder 21.67 15.37 4 52552 59063 90516828
Injection site coldness 21.60 15.37 6 52550 99 90575792
White blood cell count decreased 21.54 15.37 40 52516 167069 90408822
Manufacturing product shipping issue 21.33 15.37 6 52550 104 90575787
Osteoporosis 21.24 15.37 15 52541 96516 90479375
Autoimmune disorder 21.13 15.37 9 52547 76735 90499156
Overdose 21.00 15.37 37 52519 157672 90418219
Loss of personal independence in daily activities 20.92 15.37 29 52527 136076 90439815
Exostosis 20.83 15.37 3 52553 53131 90522760
Hypoxia 20.73 15.37 8 52548 72391 90503500
Dyspnoea exertional 20.68 15.37 8 52548 72280 90503611
Wrong schedule 20.68 15.37 8 52548 386 90575505
Exposure during pregnancy 20.66 15.37 70 52486 238340 90337551
Liver disorder 20.54 15.37 24 52532 121245 90454646
Fluid retention 20.31 15.37 13 52543 88078 90487813
Necrosis 20.28 15.37 22 52534 6588 90569303
Neoplasm malignant 20.26 15.37 54 52502 33826 90542065
Normal newborn 20.22 15.37 43 52513 23319 90552572
Injection site cellulitis 20.21 15.37 12 52544 1509 90574382
Hepatic cirrhosis 19.83 15.37 6 52550 63247 90512644
Diplopia 19.48 15.37 48 52508 28666 90547225
Depressed level of consciousness 19.31 15.37 9 52547 72775 90503116
Myelitis 19.13 15.37 13 52543 2065 90573826
Scar 19.08 15.37 33 52523 15362 90560529
Atrial fibrillation 19.04 15.37 30 52526 133581 90442310
Anaplastic large cell lymphoma T- and null-cell types 18.90 15.37 5 52551 68 90575823
Herpes simplex reactivation 18.88 15.37 10 52546 1009 90574882
Injection site fibrosis 18.83 15.37 4 52552 19 90575872
Device malfunction 18.61 15.37 39 52517 20938 90554953
Frequent bowel movements 18.59 15.37 5 52551 56930 90518961
Uterine leiomyosarcoma 18.50 15.37 4 52552 21 90575870
Asthenia 18.45 15.37 422 52134 533329 90042562
Near death experience 18.10 15.37 9 52547 796 90575095
Drug ineffective for unapproved indication 18.06 15.37 8 52548 66636 90509255
Nasal sinus cancer 18.04 15.37 4 52552 24 90575867
Skin irritation 17.97 15.37 30 52526 13573 90562318
Swelling 17.94 15.37 156 52400 418902 90156989
Nonspecific reaction 17.75 15.37 14 52542 2795 90573096
Rhabdomyolysis 17.71 15.37 4 52552 51252 90524639
Oxygen saturation decreased 17.44 15.37 22 52534 107461 90468430
Spinal cord operation 17.28 15.37 3 52553 3 90575888
Musculoskeletal pain 17.18 15.37 47 52509 171204 90404687
Caesarean section 17.02 15.37 35 52521 18542 90557349
Eye swelling 16.73 15.37 46 52510 29340 90546551
Neuralgia 16.65 15.37 48 52508 31452 90544439
Blindness 16.55 15.37 43 52513 26525 90549366
Hypoglycaemia 16.53 15.37 10 52546 69838 90506053
Micturition urgency 16.51 15.37 26 52530 11207 90564684
Post procedural complication 16.42 15.37 35 52521 19007 90556884
Injection site extravasation 16.30 15.37 23 52533 8996 90566895
Injection site oedema 16.16 15.37 11 52545 1752 90574139
Pregnancy 16.08 15.37 75 52481 61972 90513919
Thyroid cancer 16.02 15.37 19 52537 6265 90569626
Haematochezia 15.63 15.37 11 52545 70902 90504989
Ataxia 15.37 15.37 33 52523 18009 90557882
Anal incontinence 15.37 15.37 31 52525 16199 90559692

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Multiple sclerosis relapse 1303.94 24.65 364 11061 13900 42596010
Injection site reaction 915.23 24.65 283 11142 15438 42594472
Injection site pain 525.79 24.65 272 11153 57526 42552384
Injection site erythema 485.82 24.65 188 11237 20007 42589903
Immediate post-injection reaction 334.23 24.65 50 11375 36 42609874
Multiple sclerosis 268.61 24.65 94 11331 7504 42602406
Injection site swelling 255.06 24.65 113 11312 16860 42593050
Injection site mass 220.87 24.65 84 11341 8491 42601419
Injection site necrosis 214.13 24.65 46 11379 558 42609352
Injection site pruritus 199.37 24.65 80 11345 9325 42600585
Fall 148.49 24.65 242 11183 234278 42375632
Flushing 141.29 24.65 100 11325 36928 42572982
Injection site urticaria 135.61 24.65 46 11379 3337 42606573
Hypoaesthesia 125.36 24.65 123 11302 71340 42538570
Injection site bruising 109.47 24.65 56 11369 11469 42598441
Gait disturbance 107.86 24.65 132 11293 97868 42512042
Balance disorder 106.69 24.65 94 11331 47551 42562359
Embolia cutis medicamentosa 103.40 24.65 23 11402 331 42609579
Urticaria 98.58 24.65 110 11315 73926 42535984
Central nervous system lesion 85.81 24.65 42 11383 7828 42602082
Off label use 84.64 24.65 33 11392 638302 41971608
Magnetic resonance imaging abnormal 70.83 24.65 24 11401 1734 42608176
Expanded disability status scale score increased 67.10 24.65 17 11408 437 42609473
Secondary progressive multiple sclerosis 63.51 24.65 16 11409 402 42609508
Progressive multiple sclerosis 60.37 24.65 14 11411 245 42609665
Product substitution issue 58.71 24.65 37 11388 11253 42598657
Product dose omission issue 58.26 24.65 128 11297 154237 42455673
Chills 57.78 24.65 96 11329 93970 42515940
Motor dysfunction 56.14 24.65 32 11393 8114 42601796
Acute kidney injury 55.55 24.65 15 11410 367322 42242588
Urinary tract infection 55.28 24.65 97 11328 99187 42510723
Injection site discolouration 53.67 24.65 20 11405 1906 42608004
Injection site irritation 52.75 24.65 19 11406 1645 42608265
Fatigue 51.81 24.65 242 11183 435399 42174511
Chest discomfort 51.81 24.65 74 11351 63542 42546368
Injection site induration 51.63 24.65 23 11402 3464 42606446
Tremor 50.50 24.65 92 11333 96837 42513073
Injection site scar 47.88 24.65 13 11412 440 42609470
Muscular weakness 47.01 24.65 82 11343 83416 42526494
Toxicity to various agents 46.64 24.65 4 11421 229132 42380778
Injection site rash 46.38 24.65 25 11400 5687 42604223
Injection site vesicles 45.35 24.65 16 11409 1304 42608606
Influenza like illness 45.24 24.65 49 11376 31791 42578119
Muscle spasms 45.23 24.65 82 11343 85962 42523948
Depression 45.01 24.65 95 11330 111268 42498642
Injection site atrophy 44.63 24.65 9 11416 78 42609832
Anaemia 41.29 24.65 12 11413 280266 42329644
Hypersensitivity 39.34 24.65 70 11355 72300 42537610
Therapy cessation 39.18 24.65 37 11388 20413 42589497
Gait inability 37.55 24.65 38 11387 22795 42587115
Injection site inflammation 36.23 24.65 13 11412 1113 42608797
Paraesthesia 36.07 24.65 68 11357 73391 42536519
Toxic neuropathy 35.74 24.65 11 11414 584 42609326
Injection site warmth 34.37 24.65 16 11409 2667 42607243
Therapy change 33.46 24.65 18 11407 4077 42605833
Memory impairment 33.16 24.65 53 11372 50169 42559741
Burning sensation 32.79 24.65 34 11391 20979 42588931
Palpitations 32.71 24.65 53 11372 50744 42559166
Neutropenia 32.32 24.65 7 11418 199424 42410486
Injection site haemorrhage 32.08 24.65 26 11399 11710 42598200
Visual impairment 30.55 24.65 47 11378 43066 42566844
Drug interaction 30.27 24.65 17 11408 266982 42342928
Dyspnoea 30.08 24.65 212 11213 442409 42167501
Injection site scab 30.07 24.65 6 11419 49 42609861
Muscle spasticity 29.69 24.65 20 11405 6802 42603108
Injection site haematoma 29.47 24.65 13 11412 1912 42607998
Coronavirus infection 29.41 24.65 18 11407 5196 42604714
Swelling face 28.44 24.65 36 11389 27518 42582392
Hypotension 28.35 24.65 17 11408 257614 42352296
Thrombocytopenia 28.27 24.65 8 11417 190271 42419639
Pleurothotonus 28.08 24.65 11 11414 1200 42608710
Optic neuritis 27.81 24.65 16 11409 4126 42605784
Product use in unapproved indication 26.95 24.65 8 11417 184448 42425462
Wrong device used 26.13 24.65 5 11420 32 42609878
Demyelination 24.68 24.65 14 11411 3515 42606395

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Multiple sclerosis relapse 3474.62 17.27 1124 41501 49116 110497558
Injection site reaction 2636.39 17.27 1064 41561 88006 110458668
Injection site pain 1908.77 17.27 1055 41570 176867 110369807
Injection site erythema 1652.40 17.27 779 41846 93397 110453277
Injection site mass 1202.45 17.27 425 42200 24188 110522486
Injection site swelling 1033.36 17.27 495 42130 61295 110485379
Injection site pruritus 981.67 17.27 451 42174 50807 110495867
Immediate post-injection reaction 803.53 17.27 140 42485 291 110546383
Injection site urticaria 749.23 17.27 273 42352 16942 110529732
Flushing 605.79 17.27 420 42205 104316 110442358
Multiple sclerosis 554.79 17.27 246 42379 25452 110521222
Injection site bruising 525.86 17.27 296 42329 50967 110495707
Fall 398.70 17.27 779 41846 602703 109943971
Chills 357.74 17.27 403 42222 190177 110356497
Hypoaesthesia 298.10 17.27 476 42149 313747 110232927
Injection site necrosis 292.58 17.27 78 42547 1688 110544986
Product dose omission issue 284.28 17.27 472 42153 321310 110225364
Off label use 275.20 17.27 118 42507 1500067 109046607
Urticaria 240.15 17.27 436 42189 318421 110228253
Therapy cessation 229.29 17.27 167 42458 44690 110501984
Central nervous system lesion 219.10 17.27 111 42514 15442 110531232
Injection site atrophy 217.17 17.27 48 42577 451 110546223
Balance disorder 210.89 17.27 242 42383 116318 110430356
Influenza like illness 206.32 17.27 210 42415 88202 110458472
Product substitution issue 203.97 17.27 121 42504 22940 110523734
Injection site induration 201.62 17.27 95 42530 11288 110535386
Embolia cutis medicamentosa 200.47 17.27 51 42574 912 110545762
Tremor 182.85 17.27 300 42325 201932 110344742
Palpitations 181.59 17.27 263 42362 158949 110387725
Magnetic resonance imaging abnormal 180.66 17.27 65 42560 3880 110542794
Gait disturbance 174.34 17.27 352 42273 277856 110268818
Chest discomfort 173.77 17.27 270 42355 173578 110373096
Injection site warmth 168.92 17.27 97 42528 17308 110529366
Acute kidney injury 168.09 17.27 23 42602 635407 109911267
Injection site haemorrhage 162.09 17.27 120 42505 32908 110513766
Optic neuritis 155.38 17.27 79 42546 11068 110535606
Injection site scar 154.55 17.27 43 42582 1097 110545577
Injection site irritation 152.62 17.27 61 42564 4863 110541811
Throat tightness 138.71 17.27 110 42515 33379 110513295
Toxicity to various agents 138.04 17.27 13 42612 480542 110066132
Lipodystrophy acquired 133.16 17.27 54 42571 4470 110542204
Lipoatrophy 129.14 17.27 33 42592 601 110546073
Secondary progressive multiple sclerosis 119.96 17.27 38 42587 1531 110545143
Injection related reaction 119.75 17.27 38 42587 1540 110545134
Burning sensation 118.93 17.27 140 42485 69072 110477602
Anaemia 118.91 17.27 32 42593 547054 109999620
Dyspnoea 118.14 17.27 779 41846 1106093 109440581
Injection site rash 116.96 17.27 86 42539 23333 110523341
Therapy change 116.93 17.27 63 42562 9934 110536740
Urinary tract infection 108.85 17.27 324 42301 325958 110220716
Paraesthesia 107.26 17.27 290 42335 276231 110270443
Injection site discolouration 105.45 17.27 57 42568 9046 110537628
Motor dysfunction 105.02 17.27 82 42543 24324 110522350
Chest pain 103.82 17.27 350 42275 376025 110170649
Erythema 103.52 17.27 296 42329 291151 110255523
Expanded disability status scale score increased 99.14 17.27 29 42596 889 110545785
Product use in unapproved indication 97.50 17.27 26 42599 447351 110099323
Rheumatoid arthritis 94.93 17.27 5 42620 299608 110247066
Memory impairment 94.56 17.27 224 42401 196720 110349954
Progressive multifocal leukoencephalopathy 90.76 17.27 76 42549 24880 110521794
Fatigue 90.27 17.27 786 41839 1215172 109331502
Infusion related reaction 87.22 17.27 20 42605 381142 110165532
Depression 81.27 17.27 288 42337 317047 110229627
Stomatitis 81.15 17.27 6 42619 270236 110276438
Injection site nodule 79.90 17.27 38 42587 4608 110542066
General physical health deterioration 79.85 17.27 32 42593 425263 110121411
Swelling face 79.38 17.27 134 42491 92187 110454487
Injection site indentation 78.44 17.27 19 42606 275 110546399
Decreased appetite 76.83 17.27 44 42581 475802 110070872
Muscle spasms 76.04 17.27 258 42367 277899 110268775
Loss of consciousness 74.19 17.27 204 42421 196102 110350572
Lower respiratory tract infection 74.14 17.27 5 42620 243101 110303573
Feeling hot 74.07 17.27 129 42496 90977 110455697
Drug interaction 72.88 17.27 52 42573 500131 110046543
Pericarditis 71.52 17.27 3 42622 219111 110327563
Joint swelling 71.41 17.27 41 42584 442804 110103870
Thrombocytopenia 71.00 17.27 23 42602 348862 110197812
Injection site inflammation 69.97 17.27 35 42590 4736 110541938
Immune reconstitution inflammatory syndrome 68.69 17.27 54 42571 16172 110530502
Completed suicide 68.37 17.27 7 42618 242374 110304300
Injection site vesicles 66.16 17.27 33 42592 4438 110542236
Needle fatigue 66.15 17.27 23 42602 1241 110545433
Neutropenia 65.85 17.27 31 42594 374589 110172085
Pneumonia 65.70 17.27 151 42474 876563 109670111
Dizziness 65.66 17.27 477 42148 697716 109848958
Feeling cold 65.55 17.27 73 42552 33914 110512760
Hypotension 63.46 17.27 65 42560 523784 110022890
Systemic lupus erythematosus 63.06 17.27 11 42614 254327 110292347
Diarrhoea 62.91 17.27 227 42398 1139278 109407396
Pancytopenia 61.95 17.27 5 42620 209608 110337066
Hyponatraemia 59.58 17.27 7 42618 217646 110329028
Drug abuse 56.05 17.27 3 42622 177408 110369266
Visual impairment 55.11 17.27 144 42481 134284 110412390
Seizure 55.10 17.27 199 42426 220986 110325688
Abortion spontaneous 55.02 17.27 67 42558 34215 110512459
Psoriatic arthropathy 54.68 17.27 6 42619 196755 110349919
Fibromyalgia 53.65 17.27 3 42622 170906 110375768
Arthropathy 53.34 17.27 22 42603 287500 110259174
Platelet count decreased 52.87 17.27 12 42613 230431 110316243
Intentional product use issue 52.85 17.27 15 42610 247891 110298783
Therapeutic product effect incomplete 52.67 17.27 11 42614 223794 110322880
Malignant neoplasm progression 52.04 17.27 4 42621 174563 110372111
Feeling abnormal 51.46 17.27 170 42455 180541 110366133
Blood creatinine increased 49.76 17.27 6 42619 182883 110363791
Folliculitis 49.53 17.27 4 42621 167649 110379025
C-reactive protein increased 48.71 17.27 12 42613 217907 110328767
Insurance issue 46.40 17.27 36 42589 10576 110536098
Hyperhidrosis 45.36 17.27 167 42458 187131 110359543
Muscular weakness 44.66 17.27 202 42423 248266 110298408
Wheezing 43.49 17.27 22 42603 255208 110291466
Muscle spasticity 43.34 17.27 61 42564 35854 110510820
Irritable bowel syndrome 43.20 17.27 6 42619 164209 110382465
Muscle injury 42.62 17.27 3 42622 140804 110405870
Product storage error 42.46 17.27 47 42578 21681 110524993
Product use issue 42.06 17.27 35 42590 311660 110235014
Autonomic dysreflexia 41.97 17.27 13 42612 486 110546188
Breast cancer 41.47 17.27 62 42563 38480 110508194
Cognitive disorder 41.38 17.27 99 42526 87412 110459262
Gastrointestinal haemorrhage 41.37 17.27 7 42618 165511 110381163
Renal impairment 40.92 17.27 11 42614 188434 110358240
Incorrect dose administered by device 40.90 17.27 28 42597 6786 110539888
Lip swelling 40.21 17.27 71 42554 50596 110496078
Skin reaction 40.06 17.27 45 42580 21099 110525575
Vision blurred 40.01 17.27 125 42500 128897 110417777
Hepatic enzyme increased 39.76 17.27 39 42586 320853 110225821
Blood cholesterol increased 39.72 17.27 11 42614 184774 110361900
Osteoarthritis 39.01 17.27 11 42614 182612 110364062
Injection site scab 38.67 17.27 13 42612 633 110546041
Death 38.61 17.27 139 42486 698730 109847944
Injection site discomfort 38.22 17.27 27 42598 6880 110539794
Blister 38.14 17.27 20 42605 227356 110319318
Injection site haematoma 37.83 17.27 24 42601 5122 110541552
Respiratory failure 37.53 17.27 18 42607 215314 110331360
Therapeutic product effect decreased 37.42 17.27 24 42601 244292 110302382
Intentional overdose 36.91 17.27 4 42621 132497 110414177
Interstitial lung disease 36.86 17.27 5 42620 139329 110407345
JC polyomavirus test positive 36.74 17.27 18 42607 2329 110544345
Septic shock 36.54 17.27 8 42617 157520 110389154
Peroneal nerve palsy 36.50 17.27 27 42598 7387 110539287
Lung disorder 36.38 17.27 12 42613 180035 110366639
Overdose 35.76 17.27 23 42602 233771 110312903
Hypertension 35.64 17.27 91 42534 509993 110036681
Neutrophil count decreased 35.41 17.27 3 42622 120938 110425736
Hot flush 34.84 17.27 78 42547 65958 110480716
Wound 34.59 17.27 24 42601 234413 110312261
Bladder disorder 34.59 17.27 31 42594 11106 110535568
Coronavirus infection 34.56 17.27 29 42596 9516 110537158
Pruritus 34.45 17.27 359 42266 581201 109965473
Liver injury 34.16 17.27 8 42617 150405 110396269
Confusional state 34.00 17.27 82 42543 468598 110078076
Haemoglobin decreased 33.46 17.27 28 42597 248699 110297975
Hypoxia 33.44 17.27 5 42620 129510 110417164
Anxiety 33.04 17.27 237 42388 344841 110201833
Hypersensitivity 32.83 17.27 267 42358 403731 110142943
Demyelination 32.81 17.27 28 42597 9401 110537273
Obesity 32.67 17.27 3 42622 113348 110433326
Cardiac failure 32.22 17.27 16 42609 187610 110359064
Injection site infection 32.18 17.27 17 42608 2576 110544098
Impaired healing 31.98 17.27 18 42607 196699 110349975
Injection site ulcer 31.13 17.27 12 42613 868 110545806
No reaction on previous exposure to drug 31.11 17.27 9 42616 265 110546409
Electrocardiogram QT prolonged 31.10 17.27 3 42622 108957 110437717
Delirium 31.02 17.27 7 42618 135018 110411656
Paralysis 30.93 17.27 34 42591 15566 110531108
Joint range of motion decreased 30.78 17.27 5 42620 121827 110424847
Muscle tightness 30.71 17.27 33 42592 14729 110531945
Type 2 diabetes mellitus 30.60 17.27 15 42610 177217 110369457
Speech disorder 30.57 17.27 71 42554 61498 110485176
Asthma 30.33 17.27 31 42594 250260 110296414
Oedema 30.32 17.27 22 42603 209954 110336720
Oedema peripheral 30.27 17.27 50 42575 328610 110218064
Injection site cellulitis 30.16 17.27 15 42610 2005 110544669
Gastrooesophageal reflux disease 29.93 17.27 16 42609 179960 110366714
Renal failure 29.87 17.27 26 42599 226548 110320126
Relapsing-remitting multiple sclerosis 29.73 17.27 15 42610 2067 110544607
Heart rate increased 29.72 17.27 122 42503 143712 110402962
Pharyngeal oedema 29.49 17.27 34 42591 16394 110530280
White blood cell count decreased 29.43 17.27 27 42598 229363 110317311
Abdominal discomfort 29.28 17.27 68 42557 393790 110152884
Pleural effusion 29.26 17.27 16 42609 177693 110368981
Injury 29.13 17.27 16 42609 177249 110369425
Trigeminal neuralgia 28.80 17.27 19 42606 4333 110542341
Bradycardia 28.67 17.27 12 42613 155505 110391169
Vertigo 28.64 17.27 86 42539 86784 110459890
Injection site injury 28.50 17.27 12 42613 1092 110545582
Back pain 28.43 17.27 242 42383 370754 110175920
Sepsis 28.14 17.27 52 42573 327294 110219380
Rectal haemorrhage 27.96 17.27 6 42619 119827 110426847
Movement disorder 27.58 17.27 50 42575 36354 110510320
Pain in extremity 27.56 17.27 298 42327 486820 110059854
Injection site coldness 27.37 17.27 7 42618 128 110546546
Condition aggravated 26.60 17.27 170 42455 734666 109812008
Injection site hypoaesthesia 26.52 17.27 10 42615 681 110545993
Progressive multiple sclerosis 26.40 17.27 12 42613 1312 110545362
Dry mouth 26.29 17.27 23 42602 199925 110346749
Sensory disturbance 26.25 17.27 33 42592 17396 110529278
Diplopia 26.16 17.27 53 42572 41841 110504833
Atrial fibrillation 26.09 17.27 30 42595 229612 110317062
Ill-defined disorder 26.00 17.27 14 42611 156839 110389835
Bursitis 25.65 17.27 9 42616 129909 110416765
Hemiparesis 25.60 17.27 54 42571 43849 110502825
Wrong technique in product usage process 25.59 17.27 83 42542 87265 110459409
Malignant melanoma 25.47 17.27 32 42593 16859 110529815
Hypokalaemia 25.21 17.27 20 42605 182428 110364246
Arthralgia 24.95 17.27 187 42438 779445 109767229
Intentional product misuse 24.91 17.27 10 42615 132894 110413780
Limb discomfort 24.70 17.27 51 42574 40803 110505871
Hypercholesterolaemia 24.65 17.27 3 42622 90834 110455840
Injection site abscess 24.46 17.27 13 42612 1993 110544681
Maternal exposure during breast feeding 24.46 17.27 17 42608 4221 110542453
Rhabdomyolysis 24.36 17.27 8 42617 120393 110426281
Cardiac arrest 24.26 17.27 24 42601 196729 110349945
Gastrointestinal disorder 24.00 17.27 35 42590 241917 110304757
Myelitis 23.65 17.27 15 42610 3198 110543476
Sleep disorder 23.61 17.27 25 42600 198619 110348055
Primary progressive multiple sclerosis 23.44 17.27 6 42619 110 110546564
Urinary incontinence 23.00 17.27 55 42570 48532 110498142
Anaphylactic shock 22.96 17.27 57 42568 51489 110495185
Lymphopenia 22.95 17.27 49 42576 40121 110506553
Cardio-respiratory arrest 22.91 17.27 8 42617 115828 110430846
Abdominal pain 22.73 17.27 111 42514 512878 110033796
Headache 22.67 17.27 471 42154 881906 109664768
Constipation 22.60 17.27 67 42558 357719 110188955
Injection site oedema 22.57 17.27 12 42613 1842 110544832
Productive cough 22.42 17.27 8 42617 114297 110432377
Drug ineffective for unapproved indication 22.32 17.27 6 42619 102832 110443842
Panic attack 22.25 17.27 40 42585 28900 110517774
Inflammation 22.22 17.27 25 42600 193213 110353461
Hypoaesthesia oral 22.20 17.27 30 42595 16972 110529702
Injection site paraesthesia 22.03 17.27 9 42616 759 110545915
Head injury 21.78 17.27 50 42575 42967 110503707
Invasive ductal breast carcinoma 21.64 17.27 19 42606 6627 110540047
Medication error 21.32 17.27 7 42618 105359 110441315
Encephalopathy 21.22 17.27 3 42622 81052 110465622
Peripheral swelling 21.20 17.27 82 42543 403952 110142722
Haematochezia 21.15 17.27 9 42616 115515 110431159
Paraparesis 21.08 17.27 16 42609 4550 110542124
Wrong technique in device usage process 21.02 17.27 19 42606 6882 110539792
Dyspnoea exertional 20.90 17.27 7 42618 104053 110442621
Scar 20.85 17.27 29 42596 16852 110529822
Thyroid cancer 20.70 17.27 18 42607 6196 110540478
Cough 20.38 17.27 100 42525 461541 110085133
Temperature intolerance 20.36 17.27 26 42599 13924 110532750
Upper respiratory tract infection 19.96 17.27 13 42612 131315 110415359
Ataxia 19.89 17.27 39 42586 30069 110516605
Sinusitis 19.88 17.27 54 42571 296634 110250040
Urticarial vasculitis 19.86 17.27 9 42616 977 110545697
Anaphylactic reaction 19.83 17.27 92 42533 114208 110432466
Night sweats 19.39 17.27 14 42611 133969 110412705
Herpes simplex reactivation 19.29 17.27 10 42615 1458 110545216
Acute respiratory failure 19.21 17.27 3 42622 75257 110471417
Liver disorder 19.14 17.27 16 42609 142227 110404447
Anal incontinence 19.02 17.27 32 42593 21932 110524742
Manufacturing product shipping issue 18.80 17.27 5 42620 107 110546567
Skin mass 18.78 17.27 21 42604 9795 110536879
Weight decreased 18.64 17.27 105 42520 467952 110078722
Dyspepsia 18.57 17.27 28 42597 190937 110355737
Epistaxis 18.37 17.27 14 42611 130358 110416316
White matter lesion 18.17 17.27 12 42613 2742 110543932
Ophthalmic herpes zoster 18.16 17.27 13 42612 3382 110543292
Frequent bowel movements 17.88 17.27 3 42622 71387 110475287
Somnolence 17.85 17.27 57 42568 297392 110249282
Drug administered in wrong device 17.59 17.27 5 42620 138 110546536
Chronic kidney disease 17.43 17.27 4 42621 76287 110470387
Ascites 17.36 17.27 7 42618 92801 110453873
Maternal exposure during pregnancy 17.32 17.27 162 42463 254721 110291953
Oxygen saturation decreased 17.30 17.27 21 42604 156961 110389713

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC L03AX13 ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
IMMUNOSTIMULANTS
Other immunostimulants
MeSH PA D000276 Adjuvants, Immunologic
MeSH PA D007155 Immunologic Factors
MeSH PA D007166 Immunosuppressive Agents
MeSH PA D018501 Antirheumatic Agents
CHEBI has role CHEBI:35610 antineoplastic agent
CHEBI has role CHEBI:35705 immunosuppressive agent
CHEBI has role CHEBI:39456 antiglaucoma drug
CHEBI has role CHEBI:66981 ophthalmology drug

Related Drugs by ATC class:

L03AX Other immunostimulants 15 drugs
cridanimodelapegademasehistamineleniolisiblentinanmavorixaformifamurtidemotixafortidepegademasepidotimodplerixaforroquinimex show all 15 →

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Multiple sclerosis indication 24700007 DOID:2377




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
5M691HL4BO UNII
D04318 KEGG_DRUG
4020989 VUID
N0000179467 NUI
4020989 VANDF
C0289884 UMLSCUI
CHEBI:749565 CHEBI
CHEMBL1201507 ChEMBL_ID
D000068717 MESH_DESCRIPTOR_UI
135779 RXNORM
10204 MMSL
262778 MMSL
4781 MMSL
006395 NDDF
108755008 SNOMEDCT_US

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 0378-6960 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 27 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 0378-6961 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 27 sections
Glatopa HUMAN PRESCRIPTION DRUG LABEL 1 0781-3234 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 26 sections
Glatopa HUMAN PRESCRIPTION DRUG LABEL 1 0781-3250 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 26 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 0832-6084 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 25 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 0832-6085 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 25 sections
GLATIRAMER ACETATE HUMAN PRESCRIPTION DRUG LABEL 1 11797-764 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 1 sections
GLATIRAMER ACETATE HUMAN PRESCRIPTION DRUG LABEL 1 11797-765 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 1 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 47335-990 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 26 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 47335-991 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 26 sections
Glatopa HUMAN PRESCRIPTION DRUG LABEL 1 63629-8815 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 26 sections
Glatopa HUMAN PRESCRIPTION DRUG LABEL 1 63629-8816 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 26 sections
Copaxone HUMAN PRESCRIPTION DRUG LABEL 1 68546-317 INJECTION, SOLUTION 20 mg SUBCUTANEOUS NDA 25 sections
Copaxone HUMAN PRESCRIPTION DRUG LABEL 1 68546-325 INJECTION, SOLUTION 40 mg SUBCUTANEOUS NDA 25 sections
GLATIRAMER ACETATE HUMAN PRESCRIPTION DRUG LABEL 1 70710-1548 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 24 sections
GLATIRAMER ACETATE HUMAN PRESCRIPTION DRUG LABEL 1 70710-1549 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 24 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 82983-429 INJECTION, SOLUTION 20 mg SUBCUTANEOUS ANDA 27 sections
Glatiramer Acetate HUMAN PRESCRIPTION DRUG LABEL 1 82983-430 INJECTION, SOLUTION 40 mg SUBCUTANEOUS ANDA 27 sections